跳至主要内容
临床试验/EUCTR2004-002821-30-LT
EUCTR2004-002821-30-LT进行中(未招募)不适用

Study of the efficacy of intravesical instillations of interleukin-2 in treatment of superficial bladder cancer

Institute of Oncology, Vilnius University0 个研究点目标入组 70 人开始时间: 2004年10月11日最近更新:

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. Signed patient informed consent form
  • 2. Histologically confirmed diagnosis of multifocal Ta,T1 /G1,G2 superficial bladder cancer
  • 3. WHO-performance status 0-2
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1. The presence of a cancer type other than transitional cell carcinoma
  • 2. Previous intravesical chemotherapy within 3 months before treatment
  • 3. Previous radiotherapy to the bladder
  • 4. Urinary tract infection
  • 5. Decompensated cardiovascular, renal or liver diseases

研究者

发起方
Institute of Oncology, Vilnius University

相似试验